OpenVSafe by OpenVAERS
Search V-safe

ZVY-32075-36733

2 vaccinations 3 coded responses 19 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
032 / NH
Registered
2022-07-20
Relationship
Child or adolescent in my care
Guardian
H4B-23007-58531
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-07-20
    Registered in v-safe
  2. 2022-07-20
    Dose 1 — Pfizer-BioNTech
  3. 2022-07-20
    Health check-in — day 0, dose 1, under 3
    Feeling: Fair · Site: Pain, Redness · Sleepiness, Irritability/crying
    Under 3 check-in
  4. 2022-07-21
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-07-22
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Sleepiness, Irritability/crying
    Under 3 check-in
  6. 2022-07-23
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-07-24
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-07-25
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-07-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Diarrhea
    Under 3 check-in
  10. 2022-07-27
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-08-03
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-08-10
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-08-24
    Survey response — day 35, dose 1, under 3
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-09-02
    Health check-in — day 42, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-09-27
    Dose 2 — Pfizer-BioNTech
    Co-administered: Chickenpox:MMR
  16. 2022-10-14
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  17. 2022-10-18
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  18. 2022-10-25
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  19. 2022-11-01
    Survey response — day 35, dose 2, under 3
    MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Severe cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-11-08
    Survey response — day 42, dose 2, under 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: RSV
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-12-27
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2023-03-28
    Health check-in — 6 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-07-20Pfizer-BioNTech No
22022-09-27Pfizer-BioNTech Chickenpox:MMR

Free text

Release 12 (Under 3) — day 35, dose 1, under 3

2022-08-24

Symptoms: Cold symptoms

Release 12 (Under 3) — day 35, dose 2, under 3

2022-11-01

Symptoms: Severe cold symptoms

Release 12 (Under 3) — day 42, dose 2, under 3

2022-11-08

Symptoms: RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDRespiratory syncytial virus infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…